Back to NAI500

Company Profile

As an innovative biotech, it was founded by senior scientists of Amgen in United States. With a global vision and an international team, the company focuses on ophthalmology (indications: dAMD & Stargardt) and digestion (indications: IBS & Carcinoid Syndrome) through a differentiated R&D strategy.

Corporate Speaker

Dejian Xie, Dr.

Co-founder & CEO

  • Ph.D., Texas Christian University, postdoc, Washington University
  • Senior scientist, AMRI in the United States
  • Head chemist, AMRI in Singapore
  • Vice President, Shanghai ChemPartner
  • General Manager Chengdu ChemPartner
  • Comprehensive management/operation of innovative drug CRO
  • Led or participated 7 compounds entered clinic trials

Company Website

Agenda

Agenda